Dr. Bhadelia is the founding director of BU Center on Emerging Infectious Diseases. She is a board-certified infectious diseases physician and an Associate Professor at the BU School of Medicine. She served as the Senior Policy Advisor for Global COVID-19 Response for the White House COVID-19 Response Team in 2022-2023, where she coordinated the interagency programs for global COVID-19 vaccine donations from the United States and was the policy lead for Project NextGen, $5B HHS program aimed at developing next generation vaccines and treatments for pandemic prone coronaviruses. She also served as the interim Testing Coordinator for the White House MPOX Response Team. She is the Founding Director and co-founder of Biothreats Emergence, Analysis and Communications Network (BEACON), an open source outbreak surveillance program. 

Between 2011-2021, Dr. Bhadelia helped develop and then served as the medical director of the Special Pathogens Unit (SPU) at Boston Medical Center, a medical unit designed to care for patients with highly communicable diseases, and a state designated Ebola Treatment Center. She was previously an associate director for BU’s maximum containment research program, the National Emerging Infectious Diseases Laboratories. She has provided direct patient care and been part of outbreak response and medical countermeasures research during multiple Ebola virus disease outbreaks in West and East Africa between 2014-2019. She was the clinical lead for a DoD-funded viral hemorrhagic fever clinical research unit in Uganda, entitled Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program between 2017 and 2022. Currently, she is a co-director of Fogarty funded, BU-University of Liberia Emerging and Epidemic Viruses Research training program. She was a member of the World Health Organization (WHO)’s Technical Advisory Group on Universal Health and Preparedness Review (UHPR).  She currently serves as a member of the National Academies Forum on Microbial Threats and the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats.  She previously served as the chair of the National Academies Workshop Committee for Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) and member of the Ad Hoc Committee on Current State of Research, Development, and Stockpiling of Smallpox Medical Countermeasures. She is also a member of the Pan American Health Organization’s Strategic Advisory Group on Epidemic and Pandemic Prevention and Preparedness.

Dr. Bhadelia’s research focuses on operational global health security and pandemic preparedness, including medical countermeasure evaluation and clinical care for emerging infections, diagnostics evaluation and positioning, infection control policy development, and healthcare worker training. She has health system response experience with pathogens such as H1N1, Zika, Lassa fever, Marburg virus disease, and COVID-19 at the state, national, and global levels. 

Dr. Bhadelia has served on state, national, and interagency groups focused on biodefense priority setting, development of clinical care guidelines, and medical countermeasures research. She has served as a subject matter expert to the US Centers for Disease Control and Prevention, Department of Defense (DoD), White House Office of Science and Technology Policy (OSTP) and World Bank. She is an adjunct professor at Fletcher School of Law and Diplomacy at Tufts University since 2016, where she teaches on global health security and emerging pathogens. 

She has publications in Nature, Science, New England Journal of Medicine and other prestigious journals, as well as in press including Washington Post, and The Atlantic and Time magazines. Her work has been featured in documentaries by National Geographic as well as NOVA. She was an NBC/MSNBC medical contributor between 2020-2022 during the COVID-19 pandemic.

Patrick Bilbo serves as Chief Operating Officer of Organogenesis since 2017. Previously, he served as Senior Vice President, Regulatory, Government Affairs and Administration and other executive positions from 1999 to 2017. His career in regenerative medicine, biotechnology and medical devices spans more than 30 years, and he has had a technical and leadership role in the successful development and commercialization of numerous products. Prior to joining Organogenesis, he held management and research positions at Hologic Corporation (Cytyc), Stryker Corporation and Harvard Medical School. Mr. Bilbo earned an M.B.A. from the Boston University Questrom School of Business, and Masters Degrees in Biology and Technology Strategy & Policy from the Boston University Graduate School of Arts & Sciences, and a B.S. degree in Biology from Syracuse University.

Brady Case, MD is a child psychiatrist and cofounder and chief executive officer of Braver. Previously he was medical director of the Bradley Hospital Pediatric Anxiety Research Center, director of the Bradley Health Services Research program, and associate director of residency training in child psychiatry at Brown Medical School. Brady’s research has focused on access and quality of pediatric mental health care in the US using epidemiologic and pseudoepidemiologic methods and has been supported by the National Institutes of Health, the Patient-Centered Outcomes Research Institute, and the American Academy of Child and Adolescent Psychiatry.

Dr. Philip A. Chan, MD, MS, is a Professor in the Department of Medicine and School of Public Health at Brown University. Dr. Chan is Chief Medical Officer at Open Door Health, a community-based public health clinic in Providence, Rhode Island. Dr. Chan also serves as Consultant Medical Director for the Rhode Island Department of Health. He has led multiple public health initiatives related to preventative health, is a member of the Presidential Council for HIV/AIDS (PACHA), and is an author of the Centers for Disease Control and Prevention (CDC) STI Treatment Guidelines.

Shawn Frederick has 26 years of experience in the medical device industry specializing in tissue regeneration and wound healing.  He currently serves as the Senior Director of Medical Sciences for Organogenesis, where he leads medical and scientific education efforts. Shawn is board certified in medical affairs and oversees a team of highly qualified Medical Science Liaisons who assist with KOL development, investigator-initiated research, and field-based portfolio education.  He has a Master of Science degree with an emphasis in human physiology and sports medicine.

Abbe Garcia, PhD is a clinical psychologist and cofounder and chief clinical officer of Braver.  Previously she was clinical director of the Bradley Hospital Pediatric Anxiety Research Center. As an Associate Professor at Brown Medical School, Abbe was co-investigator on the three largest treatment outcome studies for youth with obsessive-compulsive disorder funded by the National Institute of Mental Health, and her research interests have included parent-child interactions in anxious youth.  For the last 20 years, she has been a sought-after supervisor and mentor to many talented psychology and psychiatry trainees.

Peter Hollmann, MD, oversees population health and value-based care for Brown University Health, an academic medical center and practice groups of the Brown University, Warren Alpert School of Medicine. He was previously the Associate Chief Medical Officer for Blue Cross & Blue Shield of Rhode Island and had a part time geriatric primary care practice in RI for 40 years. He has over 35 years of quality improvement experience and medical management, including as a medical director of an HMO with a Medicare product, a Medicaid plan, a commercial PPO and a Medicare ACO. He has been a long-term care hospital, nursing home, and home care medical director. He has been active in creating geriatric measures for PQRS and NCQA. He is on the Board of the RI multi-payer PCMH collaborative and is active in state-wide performance measurement, improvement and transformation activities in RI. He is a longtime member of the RI Medical Society Board and a RI delegate to the AMA House of Delegates. He is a past Chair of the CPT Editorial Panel and current member of the RBRVS Update Committee (RUC). He chaired the Council on Graduate Medical Education (COGME). Much of his career has been devoted to quality improvement at the local and national level.

Linda Hurley is a nationally recognized leader in addiction treatment and behavioral healthcare with more than 40 years of experience. She has been with CODAC Healthcare since 1989 and has served as President and CEO since 2016, leading the organization’s growth as Rhode Island’s largest nonprofit provider of outpatient services for substance use and behavioral health disorders.

A pioneer in the field, Ms. Hurley launched the nation’s first comprehensive Opioid Treatment Program within a state prison and led the implementation of the first DEA-licensed mobile medical unit providing medications for opioid use disorder. She has also been instrumental in advancing tobacco-free treatment environments and integrating Motivational Interviewing into clinical practice.

Ms. Hurley is an active contributor to national policy and research and serves on multiple advisory boards. Her work continues to focus on expanding access to comprehensive, person-centered care and strengthening the behavioral health system nationwide.

Dr. Larkin previously served as the Medical Director of Inpatient Infectious Diseases Consultation Services at Rhode Island Hospital. He has also served as the Co-Director of the Pediatric HIV Clinic at Hasbro Children’s Hospital and the Medical Director of the Infectious Disease Clinic at Rhode Island Hospital. Dr. Larkin has authored many abstracts, chapters, and works in peer-reviewed journals and publications and has been recognized with multiple awards and honors. They include the 2022 Steven M. Opal Award for Teaching Excellence and the 2015 Beckwith Family Award for Outstanding Teaching, both from Brown University’s Warren Alpert Medical School. Dr. Larkin is board-certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine and in General Pediatrics by the American Board of Pediatrics. He received his medical degree from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey and completed his undergraduate degree at Boston College. 

Dr. Nunn is the Chief Executive Officer at RIPHI. She is a passionate public health advocate best known for her innovative and effective solutions to our nation’s most pressing public health problems. Dr. Nunn holds masters and doctoral degrees in global health from the Harvard School of Public Health, and completed her post-doctoral fellowship at Brown University. Dr. Nunn is also a Professor of Public Health and Medicine at Brown University, and has trained hundreds of faculty members and students from around the world in how to create creative solutions to seemingly intractable public health problems. She has received many awards for her public health service and research over the last 15 years and has led highly effective advocacy campaigns locally and nationally. Her successful advocacy campaigns include, but aren’t limited to: PrEP for All in Rhode Island, which requires insurance companies to pay for HIV prevention medications without copayments and deductibles, and Eat Well Be Well, a SNAP incentive program that provides discounts for SNAP recipients when they buy fruits and vegetables with EBT cards.

Dr. Nunn’s work has been covered by the New York Times, The Boston Globe, The Philadelphia Inquirer, PBS, National Public Radio, the BBC, and dozens of other media outlets. With a background in global health, she also wrote The Politics and History of AIDS Treatment in Brazil, which has been critically acclaimed by the Lancet and other major medical journals.

Dr. Nunn is passionate about building highly effective, interdisciplinary teams who work together to build the scientific evidence base for public health solutions to seemingly intractable public health challenges. Her work has been elevated by her amazing team of public health leaders at RIPHI, and her community partners.

Dr. Nunn is a vocal advocate for social justice, which was informed by her childhood growing up in Little Rock, Arkansas. She is an alumna of Little Rock Central High, forcibly integrated by the National Guard in 1957. Dr. Nunn loves to travel and has lived all over the world. One of her passions is studying foreign languages! She speaks fluent Spanish and Portuguese and is conversant in German and French.

Akash Parvatikar received his PhD in Computational Biology from the Joint Carnegie-Mellon and University of Pittsburgh School of Medicine. He specializes in biomedical imaging informatics and computational and systems pathology. Akash investigates the intrinsic characteristics of biomedical images at multi-scale resolutions using statistical modeling, computer vision, machine learning, and graph-based deep learning techniques. At HistoWiz, Akash develops tools to ensure quality images, accelerates histopathology, and develops AI tools for preclinical researchers across academic, biotech, and pharmaceutical domains. 

Angela is an advanced practice registered nurse, Enterprise CNO, Vice President, and Chief Nurse Practitioner Officer of Retail Health at CVS Health. In her Enterprise CNO role, Angela leads the strategic plan to advance the recruitment, retention, resilience, and recognition of the enterprise’s more than 18,000 nurses. In her Retail Health role, Angela provides clinical and professional practice governance for 2,400 nurse practitioners, physician associates, and nurses who staff MinuteClinic’s virtual care practice as well as MinuteClinic locations across the U.S. 

Before joining CVS Health, Angela spent 20 years as a primary care provider and Clinical Director in an urban-based, family medical practice she co-owned. She also served for 10 years as a principal lecturer and clinical instructor for the Family Nurse Practitioner program in the School for Health Studies at Simmons University in Boston. Angela holds board member appointments with the Convenient Care Association, The Schwartz Center for Compassionate Healthcare, Woods System of Care, Simmons University, and Nurses MC. She also is a member of the President’s Nurse Advisory Council for John’s Hopkins School of Nursing and MGB Institute of Health Professions.

During her 19 years with CVS Health, MinuteClinic has evolved and today offers primary care services, including wellness and annual exams, chronic condition management and health screenings. The national practice supports over 5 million patients each year with accessible, high-quality care available in-person and virtually. In addition, under Angela’s leadership MinuteClinic has received accreditation from The Joint Commission, which it has maintained since 2006 and has industry-leading patient satisfaction scores. Angela received the 2018 AANP Sharp Cutting-Edge Award for her exemplary work in nursing organizational leadership and was inducted in 2019 as a Fellow of the AANP.

Angela received her BSN from Simmons College in 1985 and worked as an RN at Beth Israel Hospital in Boston.  In 1988, she received her MSN and certification as a Nurse Practitioner from Simmons College with distinction. Angela received her Executive DNP from MGH Institute of Health Professions in 2016 and was awarded the institution’s Bette Ann Harris Distinguished Alumni Award in 2023. 

Dr. Riesco serves as Senior Director, Medical Affairs for Organogenesis and joined the company in 2016 as a Medical Science Liaison. Prior to joining Organogenesis, Dr. Riesco practiced as a Podiatric Physician and Surgeon with a focus and specialty in wound care and diabetic limb salvage. She received her Doctorate in Podiatric Medicine from Barry University and completed her three-year podiatric surgical residency in South Miami Hospital located in Miami, Florida. In addition to her DPM degree, Dr. Riesco also graduated with a Master’s in Physical Therapy from Florida International University and worked in an outpatient orthopedic setting.

Dr. Rivkees is Professor of Practice and Acting Dean of Education at the Brown University School of Public Health.  Dr. Rivkees is a pediatric endocrinologist and physician-scientist who served as Florida’s State Surgeon General and Secretary of Health from June 2019 to September 2021. As State Surgeon General, Dr. Rivkees also served as State Health Officer for the Florida Department of Health.

Dr. Rivkees graduated from Rutgers University and the University of Medicine and Dentistry of New Jersey. He received residency, fellowship, and postdoctoral training and served as faculty at Massachusetts General Hospital and Harvard Medical School. Before moving to Florida, Dr. Rivkees served as Professor of Pediatrics with tenure at Yale University.  From 2012 to 2019, Dr. Rivkees was Chair of the Department of Pediatrics at the University of Florida College of Medicine.  

During his career, Dr. Rivkees has been named “One of America’s Best Doctors,” “One of America's Top Pediatricians," and “One of New York’s Best Doctors.” He is a member of the American Society for Clinical Investigation, the Connecticut Academy of Science, and Fellow of the American Academy for the Advancement of Science. Dr. Rivkees is recipient of the Pioneer Award from CARES, the Special Service Award from the American Academy of Pediatrics, and the American Thyroid Association’s Paul Starr Award.  Based on his publication record and citations, in 2026, Scholar GPS ranked him as the #1 Pediatric Endocrinologist in the world. Dr. Rivkees has had more than 35 years of continuous research funding from the National Institutes of Health. He has more than 300 publications. 

He is currently President of the Rhode Island Chapter of the American Academy of Pediatrics.  At Brown University, Dr. Rivkees focuses on pandemic preparedness and response, leadership training, and graduate education. He is a regular contributor to TIME, The Hill, and other media sources about public health-related issues. 

Jennifer Tomasik, Vice President and Principal, is a second-generation owner of CFAR and serves as a member of the firm’s Board of Directors. She is skilled at creating and directing processes that clarify strategy, solve complex organizational challenges, ensure sustainable implementation, and build effective leaders and teams. Her approach blends qualitative methods and quantitative analytics, with an emphasis on communication and collaboration, enabling people to discuss their most pressing issues in a safe and productive environment. She is a recognized expert at large group event design and facilitation.

While Jennifer leads CFAR’s Healthcare practice, she has had the privilege of working with mission-oriented leaders across many industries for more than two decades. She is a deep believer in the power of systems-thinking and the role of active engagement of people across all levels of an organization to shape, own, and contribute to their strategic future. Jennifer is proficient at bringing stakeholders together in ways that bridge the organizational and professional boundaries that often impede productive dialogue and strategic change. She helps her clients move from ideas to action, whether that be through individual or team-based coaching or leading large-scale strategy and change work.

Jennifer is an experienced speaker and author, and has presented to numerous client audiences, including the American College of Healthcare Executives, the Association of American Medical Colleges, the American Hospital Association, and the American Organization of Nurse Executives, among others. Her published work has appeared in the Wharton Healthcare Quarterly, Healthcare Executive, the American Journal of Medicine and several books focused on population health and healthcare management. Her most recent publication, Lessons from the Field: Promising Interprofessional Collaboration Practices, was produced as the result of a Robert Wood Johnson Foundation project that she led to identify effective interprofessional collaboration practices that create a culture of health and improve patient-centered care.

Jennifer is deeply committed to improving healthcare, leadership and education in her home state of Rhode Island, where she resides with her husband and daughters. She is a Fellow of the American College of Healthcare Executives (ACHE), and was elected to represent the state on ACHE’s national Board of Regents. In 2011, she won the Regent Award for Early Careerist from the American College of Healthcare Executives Rhode Island (ACHERI), where she serves as a member of the Board. She is the Immediate-Past President of the Board of Trustees of the French American School of Rhode Island, where she lead strategic planning, search, transition and governance efforts. Jennifer is a member of the Omicron II class of Leadership Rhode Island. She earned a Bachelor of Arts in American Studies from Tufts University, holds a Master of Science in Health Policy and Management from the Harvard T.H. Chan School of Public Health, and is certified as a Predictive Index Practitioner.

Rahul is a primary care and addiction medicine physician who continues to care for patients weekly at Amos House, a nonprofit in Providence. He also helps lead ITO Health, a health technology company founded in 2025 that empowers healthcare organizations to identify and address patients’ social needs.